The increase in IL-6 levels during obesity has been linked to β-cell compensatory insulin hypersecretion as it can act directly on pancreatic β-cells, enhancing glucose-stimulated insulin secretion (GSIS) without affecting insulin content [229]. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.